Data obtained from the TIMER 2.0 platform, which integrates gene expression with mutational profiles, revealed significant associations between increased expression of MAP2K4 and MAPK8 and the presence of BRAF mutations, as well as between MAP2K4 expression and TGFB1 mutations in CRC. The gene discussed is BRAF; the disease is colorectal carcinoma.